UBS Group AG (UBS) Financials

UBS

FY2025 annual

Revenue $49.6B +2.0% YoY

Net Income $7.8B +51.5% YoY

EPS (Diluted) Not reported for FY2025

Operating Cash Flow $21.9B +566.4% YoY

Market Cap $145.2B as of Oct 8, 2026

Price / Sales 2.9x on $49.6B revenue, FY2025

Price / Earnings 18.6x on $7.8B net income, FY2025

Price / Book 1.6x on $90.5B equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 8, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Mar 9, 2026 Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Mar 9, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the UBS SEC filings page.

UBS Group AG (UBS) reported $49.6B in revenue for fiscal year 2025, up 2.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI UBS FY2025 2026-10-04

UBS operates with a vast, highly leveraged balance sheet, while earnings and cash generation move far more unevenly than revenue.

FY2025 revenue reached $49.6B while net margin was 15.7%, down sharply from FY2023; the business therefore cannot be read as a simple volume-growth story. Operating cash flow was $21.9B in FY2025 after $3.3B in FY2024, showing that cash conversion can swing sharply across periods rather than track reported earnings consistently.

FY2025's asset base was $1.6T and debt-to-equity was 16.9x. With ROA at 0.5%, the balance sheet is doing most of the economic work, so relatively small changes in asset outcomes can materially affect shareholder returns.

Net income rebounded to $7.8B in FY2025, while operating cash flow reached $21.9B. That alignment is stronger than FY2024, but the wider three-year pattern still points to volatile earnings quality rather than a steady conversion of accounting profit into cash.

Financial Health Signals

Financial Health Score 21/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of UBS Group AG's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

UBS Group AG earned a return on assets of 0.5% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is up from 0.3% the prior year. Earnings ranks banks on that return over three years, and UBS Group AG scores 33/100 among other banks.

Growth

UBS Group AG reported revenue of $49.6B in fiscal year 2025, against $48.6B in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and UBS Group AG scores 60/100 among other banks.

Capital

UBS Group AG funded 5.6% of its assets with shareholders' equity at the end of fiscal year 2025, holding $90.5B of equity against $1.6T of assets. Capital ranks banks on that cushion, and UBS Group AG scores 4/100 among other banks.

Efficiency

Not available for UBS Group AG, and counted as zero in the overall score.

Credit Quality

Not available for UBS Group AG, and counted as zero in the overall score.

Stability

UBS Group AG reported net income of $7.8B in fiscal year 2025, against $5.1B in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and UBS Group AG scores 26/100 among other banks.

Piotroski F-Score Partial

5/6

UBS Group AG passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.80x

For every $1 of reported earnings, UBS Group AG generates $2.80 in operating cash flow ($21.9B OCF vs $7.8B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt

$231.4B

YoY-5.2%

QoQ-10.7%

UBS Group AG held $231.4B in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding

3.34B

YoY-3.5%

UBS Group AG had 3.34B shares outstanding in Q4 2025. This represents a decrease of 3.5% from the same quarter a year earlier.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

UBS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UBS quarterly income statement

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Revenue	$49.6B+2.0%	$48.6B+19.0%	$40.8B+18.1%	$34.6B-2.3%	$35.4B+7.0%	$33.1B+14.2%	$29.0B-4.5%	$30.3B+1.9%	$29.8B+3.4%	$28.8B
Interest Expense	$161.0M-15.7%	$191.0M+15.1%	$166.0M+80.4%	$92.0M-9.8%	$102.0M-7.3%	$110.0M-9.8%	$122.0M	N/A	N/A	N/A
Income Tax	$1.1B-37.0%	$1.7B+91.9%	$873.0M-55.0%	$1.9B-2.8%	$2.0B+26.2%	$1.6B+24.9%	$1.3B-13.7%	$1.5B-65.9%	$4.3B+454.1%	$777.0M
Net Income	$7.8B+51.5%	$5.1B-81.2%	$27.4B+257.4%	$7.7B+2.3%	$7.5B+13.9%	$6.6B+52.5%	$4.3B-4.7%	$4.5B+332.3%	$1.0B-69.5%	$3.4B
Diluted Shares (Avg)	3.29B-1.8%	3.35B+1.7%	3.30B-3.0%	3.40B-6.3%	3.63B-2.2%	3.71B-1.6%	3.77B-1.9%	3.84B+0.1%	3.84B+0.3%	3.82B

Metric	Q4'2520-F	Q2'256-K	Q1'256-K	Q4'2420-F	Q2'246-K	Q1'2410-Q	Q4'2320-F	Q2'2310-Q
Revenue	N/A	$12.1B+1.7%	$12.6B-1.4%	N/A	$11.9B+24.8%	$12.7B+45.7%	N/A	$9.5B+7.0%
Interest Expense	N/A	$43.0M-12.2%	$41.0M-18.0%	N/A	$49.0M+40.0%	$50.0M+92.3%	N/A	$35.0M+59.1%
Income Tax	N/A	-$209.0M-171.3%	$430.0M-29.7%	N/A	$293.0M-18.8%	$612.0M+33.3%	N/A	$361.0M-27.4%
Net Income	N/A	$2.4B+104.4%	$1.7B-3.5%	N/A	$1.2B-95.7%	$1.8B+70.1%	N/A	$27.3B+1190.6%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

UBS Balance Sheet

UBS quarterly balance sheet

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Total Assets	$1.6T+3.3%	$1.6T-8.8%	$1.7T+55.5%	$1.1T-1.1%	$1.1T-0.8%	$1.1T+15.8%	$972.2B+1.4%	$958.5B+2.0%	$939.3B+2.2%	$918.9B
Cash & Equivalents	$231.4B-5.2%	$244.1B-28.3%	$340.2B+74.2%	$195.3B-6.0%	$207.9B+19.8%	$173.5B+44.8%	$119.9B-4.9%	$126.1B+20.3%	$104.8B-11.9%	$119.0B
Goodwill	$6.1B+1.7%	$6.0B0.0%	$6.0B0.0%	$6.0B-1.6%	$6.1B-5.9%	$6.5B+0.2%	$6.5B-2.7%	$6.6B+1.3%	$6.6B+1.9%	$6.4B
Total Liabilities	$1.5T+3.2%	$1.5T-9.3%	$1.6T+55.7%	$1.0T-0.9%	$1.1T-0.9%	$1.1T+16.2%	$917.5B+1.3%	$905.4B+2.1%	$886.7B+2.5%	$865.3B
Total Equity	$90.5B+5.7%	$85.6B-0.7%	$86.2B+50.6%	$57.2B-6.2%	$61.0B+2.1%	$59.8B+9.3%	$54.7B+3.0%	$53.1B+1.0%	$52.6B-1.9%	$53.6B
Retained Earnings	$82.7B+6.0%	$78.0B+4.9%	$74.4B+48.8%	$50.0B+14.0%	$43.9B+13.1%	$38.8B+13.6%	$34.1B+12.2%	$30.4B+17.3%	$25.9B+3.6%	$25.0B

Metric	Q4'2520-F	Q2'256-K	Q1'256-K	Q4'2420-F	Q2'246-K	Q1'2410-Q	Q4'2320-F	Q2'2310-Q
Total Assets	$1.6T+3.3%	$1.7T+7.0%	$1.5T-3.9%	$1.6T-8.8%	$1.6T-7.0%	$1.6T+52.6%	$1.7T+55.5%	$1.7T+50.8%
Cash & Equivalents	$231.4B-5.2%	$259.1B-7.1%	N/A	$244.1B-28.3%	$279.0B-5.6%	N/A	$340.2B+74.2%	$295.7B+42.2%
Goodwill	$6.1B+1.7%	$7.0B-4.0%	$6.9B-6.4%	$6.0B0.0%	$7.3B-3.4%	$7.4B+17.7%	$6.0B0.0%	$7.6B+19.9%
Total Liabilities	$1.5T+3.2%	$1.6T+7.0%	$1.5T-4.3%	$1.5T-9.3%	$1.5T-7.2%	$1.5T+52.8%	$1.6T+55.7%	$1.6T+50.7%
Total Equity	$90.5B+5.7%	$89.7B+6.5%	$87.6B+2.7%	$85.6B-0.7%	$84.2B-2.2%	$85.3B+49.3%	$86.2B+50.6%	$86.1B+50.6%
Retained Earnings	$82.7B+6.0%	$79.7B+4.7%	$80.0B+5.4%	$78.0B+4.9%	$76.2B-2.6%	$76.0B+48.5%	$74.4B+48.8%	$78.2B+67.8%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

UBS Cash Flow Statement

UBS quarterly cash flow statement

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Operating Cash Flow	$21.9B+566.4%	$3.3B-96.2%	$86.1B+487.6%	$14.6B-53.4%	$31.4B-15.0%	$37.0B+87.6%	$19.7B-31.8%	$28.9B+155.5%	-$52.1B-184.8%	-$18.3B
Depreciation & Amortization	$3.5B-7.1%	$3.8B+1.3%	$3.8B+82.0%	$2.1B-2.7%	$2.1B-0.4%	$2.1B+9.6%	$1.9B	N/A	N/A	N/A
Investing Cash Flow	-$22.8B-3316.1%	$709.0M-99.3%	$103.1B+928.5%	-$12.4B-487.4%	-$2.1B+68.8%	-$6.8B-335.5%	-$1.6B+74.6%	-$6.1B-218.2%	$5.2B-85.8%	$36.6B
Financing Cash Flow	-$30.9B+63.3%	-$84.2B-44.5%	-$58.3B-540.7%	-$9.1B-187.9%	$10.3B-16.8%	$12.4B+148.5%	-$25.6B-13581.1%	$190.0M-99.3%	$27.0B+4509.8%	-$612.0M
Dividends Paid	$2.9B+27.0%	$2.3B+34.4%	$1.7B+0.7%	$1.7B+28.2%	$1.3B-50.1%	$2.6B+2.5%	$2.5B+4.3%	$2.4B+8.0%	$2.3B-30.3%	$3.2B
Share Buybacks	$5.4B+75.9%	$3.1B+0.7%	$3.1B-51.0%	$6.3B+77.8%	$3.5B+122.3%	$1.6B-10.6%	$1.8B+10.1%	$1.6B+77.1%	$908.0M-37.1%	$1.4B

Metric	Q4'2520-F	Q2'256-K	Q1'256-K	Q4'2420-F	Q2'246-K	Q1'2410-Q	Q4'2320-F	Q2'2310-Q
Depreciation & Amortization	N/A	$898.0M-0.6%	$861.0M-3.8%	N/A	$903.0M+4.3%	$895.0M+70.5%	N/A	$866.0M+72.2%

Not reported in any period shown, so not listed: Operating Cash Flow, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

UBS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

UBS quarterly financial ratios

Metric	FY2520-F	FY2420-F	FY2320-F	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Net Margin	15.7%+5.1pp	10.6%-56.5pp	67.1%+44.9pp	22.2%+1.0pp	21.1%+1.3pp	19.9%+5.0pp	14.9%0.0pp	14.9%+11.4pp	3.5%-8.4pp	11.9%
Return on Equity	8.6%+2.6pp	6.0%-25.8pp	31.8%+18.4pp	13.4%+1.1pp	12.3%+1.3pp	11.0%+3.1pp	7.9%-0.6pp	8.5%+6.5pp	2.0%-4.4pp	6.4%
Return on Assets	0.5%+0.1pp	0.3%-1.3pp	1.6%+0.9pp	0.7%0.0pp	0.7%+0.1pp	0.6%+0.1pp	0.4%0.0pp	0.5%+0.4pp	0.1%-0.3pp	0.4%
Debt-to-Equity	16.88-0.4x	17.29-1.6x	18.93+0.6x	18.30+1.0x	17.31-0.5x	17.84+1.1x	16.78-0.3x	17.06+0.2x	16.87+0.7x	16.15
Asset Turnover	0.030.0x	0.030.0x	0.020.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.03

Metric	Q4'2520-F	Q2'256-K	Q1'256-K	Q4'2420-F	Q2'246-K	Q1'2410-Q	Q4'2320-F	Q2'2310-Q
Net Margin	N/A	19.8%+10.0pp	13.6%-0.3pp	N/A	9.9%	13.9%+2.0pp	N/A	286.5%
Return on Equity	N/A	2.7%+1.3pp	1.9%-0.1pp	N/A	1.4%-30.3pp	2.1%+0.2pp	N/A	31.8%+28.1pp
Return on Assets	N/A	0.1%+0.1pp	0.1%0.0pp	N/A	0.1%-1.5pp	0.1%0.0pp	N/A	1.6%+1.4pp
Debt-to-Equity	16.88-0.4x	17.62+0.1x	16.62-1.2x	17.29-1.6x	17.53-0.9x	17.84+0.4x	18.93+0.6x	18.480.0x
Asset Turnover	N/A	0.010.0x	0.010.0x	N/A	0.010.0x	0.010.0x	N/A	0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
UBS Group AG UBS	FY2025	$49.6B	$7.8B	15.7%	$145.2B	21/100
Citigroup Inc. C	FY2025	$85.2B	$14.3B	16.8%	$213.6B	26/100

Where UBS Group AG Ranks

Frequently Asked Questions

What is UBS Group AG's annual revenue?

UBS Group AG (UBS) reported $49.6B in total revenue for fiscal year 2025. This represents a 2.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is UBS Group AG's revenue growing?

UBS Group AG (UBS) revenue grew by 2.0% year-over-year, from $48.6B to $49.6B in fiscal year 2025.

Is UBS Group AG profitable?

Yes, UBS Group AG (UBS) reported a net income of $7.8B in fiscal year 2025, with a net profit margin of 15.7%.

What is UBS Group AG's net profit margin?

UBS Group AG (UBS) had a net profit margin of 15.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is UBS Group AG's return on equity (ROE)?

UBS Group AG (UBS) has a return on equity of 8.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is UBS Group AG's operating cash flow?

UBS Group AG (UBS) generated $21.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are UBS Group AG's total assets?

UBS Group AG (UBS) had $1.6T in total assets as of fiscal year 2025, including both current and long-term assets.

Does UBS Group AG buy back shares?

Yes, UBS Group AG (UBS) spent $5.4B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does UBS Group AG have outstanding?

UBS Group AG (UBS) had 3.34B shares outstanding as of fiscal year 2025.

What is UBS Group AG's debt-to-equity ratio?

UBS Group AG (UBS) had a debt-to-equity ratio of 16.88 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is UBS Group AG's return on assets (ROA)?

UBS Group AG (UBS) had a return on assets of 0.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is UBS Group AG's P/E ratio?

UBS Group AG (UBS) trades at 18.6x earnings, its market capitalization divided by net income of $7.8B net income, FY2025. The market capitalization is $145.2B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is UBS Group AG's price-to-sales ratio?

UBS Group AG (UBS) trades at 2.9x sales, its market capitalization divided by revenue of $49.6B revenue, FY2025. The market capitalization is $145.2B as of Oct 8, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is UBS Group AG's Piotroski F-Score?

UBS Group AG (UBS) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are UBS Group AG's earnings high quality?

UBS Group AG (UBS) has an earnings quality ratio of 2.80x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is UBS Group AG?

UBS Group AG (UBS) scores 21 out of 100 on our Financial Health Score, indicating weak standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.